Blog

Flavio G Rocha: Dose density in neoadjuvant treatment for PDAC

Flavio Rocha/X

Feb 12, 2025, 17:33

Flavio G Rocha: Dose density in neoadjuvant treatment for PDAC

Flavio G Rocha, Hedinger Chair of Surgical Oncology and Physician-in-Chief OHSU Knight Cancer Institute, shared on X about recent paper by Sameer Patel et al., titled “Chemotherapy dose density is prognostic for overall survival in patients with resectable pancreas cancer: A landmark analysis of SWOG 1505” published on ACS Journals.

Authors: Sameer H. Patel, Sarah Colby, Davendra Sohal, Katherine A. Guthrie, Lisa A. Kachnic, E. Gabriela Chiorean, Andrew M. Lowy, Flavio G. Rocha, Howard S. Hochster, Philip A. Philip, Syed A. Ahmad

“Dose density in neoadjuvant treatment for PDAC

A landmark analysis of SWOG S1505
DD >85% pre or DD >70% periop lead to OS benefit

Kudos to investigators and lead author Dr. Sameer Patel.“

Andrew M. Lowy cancer Davendra Sohal E. Gabriela Chiorean Flavio G. Rocha Howard S Hochster Katherine A. Guthrie Lisa A. Kachnic OncoDaily Oncology Philip A. Philip Sameer H. Patel Sarah Colby Syed A. Ahmad

Eric Abidal and Liver Cancer: How He Returned to Football After Overcoming Illness

April is Head and Neck Cancer Awareness Month

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

Cancer Center Near Me: Dana-Farber Cancer Institute